This in vitro study compares hydroxyapatite precipitation across four chemically treated titanium surfaces and a bioactive glass soaked in simulated body fluid for up to 3 days. It asks whether surface OH group chemistry (quantity vs. acidic/basic strength) determines precipitation mechanism, kinetics, and the biological quality of the resulting hydroxyapatite. Zeta potential measurements and FTIR chemical imaging were used alongside conventional electron microscopy and XPS.
When selecting implant surface treatments, the speed and biological quality of hydroxyapatite formation are not the same target — and this paper clarifies why they diverge.
Ion-exchange surfaces (NaOH-treated titanium, bioactive glass) achieve faster hydroxyapatite precipitation and should be preferred when early osseointegration is the priority, such as in revision surgery, poor bone stock, or immediate loading scenarios.
Electrostatic-only surfaces (HF + H₂O₂ oxidation) carry abundant reactive OH groups yet remain at the nucleation stage at 3 days. Abundant surface hydroxyl groups do not guarantee fast or high-quality mineral deposition. The mechanism of action matters as much as the surface chemistry profile.
For applications where the biological quality of precipitated mineral matters (not just speed), NaOH + HCl + heat-treated titanium and NaOH + heat-treated Ti-6Al-4V produce type B carbonated hydroxyapatite closest to native bone, while bioactive glass and CaCl₂-treated surfaces yield a more crystalline, less bone-like mixed type.
A key limitation: all findings are in vitro in protein-free simulated body fluid. In vivo performance requires separate validation, and roughly 25% of materials that perform well in simulated body fluid do not replicate that performance in vivo.
This in vitro study compares hydroxyapatite precipitation across four chemically treated titanium surfaces and a bioactive glass soaked in simulated body fluid for up to 3 days. It asks whether surface OH group chemistry (quantity vs. acidic/basic strength) determines precipitation mechanism, kinetics, and the biological quality of the resulting hydroxyapatite. Zeta potential measurements and FTIR chemical imaging were used alongside conventional electron microscopy and XPS.
When selecting implant surface treatments, the speed and biological quality of hydroxyapatite formation are not the same target — and this paper clarifies why they diverge.
Ion-exchange surfaces (NaOH-treated titanium, bioactive glass) achieve faster hydroxyapatite precipitation and should be preferred when early osseointegration is the priority, such as in revision surgery, poor bone stock, or immediate loading scenarios.
Electrostatic-only surfaces (HF + H₂O₂ oxidation) carry abundant reactive OH groups yet remain at the nucleation stage at 3 days. Abundant surface hydroxyl groups do not guarantee fast or high-quality mineral deposition. The mechanism of action matters as much as the surface chemistry profile.
For applications where the biological quality of precipitated mineral matters (not just speed), NaOH + HCl + heat-treated titanium and NaOH + heat-treated Ti-6Al-4V produce type B carbonated hydroxyapatite closest to native bone, while bioactive glass and CaCl₂-treated surfaces yield a more crystalline, less bone-like mixed type.
A key limitation: all findings are in vitro in protein-free simulated body fluid. In vivo performance requires separate validation, and roughly 25% of materials that perform well in simulated body fluid do not replicate that performance in vivo.